Literature DB >> 9700502

IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation.

R Jefferis1, J Lund, J D Pound.   

Abstract

The Fc region of human IgG expresses interaction sites for many effector ligands. In this review the topographical distributions of ten of these sites are discussed in relation to functional requirement. It is apparent that interaction sites localised to the inter-CH2-CH3 domain region of the Fc allow for functional divalency, whereas sites localised to the hinge proximal region of the CH2 domain are functionally monovalent, with expression of the latter sites being particularly dependent on glycosylation. All x-ray crystal structures for Fc and Fc-ligand complexes report that the protein structure of the hinge proximal region of the CH2 domain is "disordered", suggesting "internal mobility". We propose a model in which such "internal mobility" results in the generation of a dynamic equilibrium between multiple conformers, certain of which express interaction sites specific to individual ligands. The emerging understanding of the influence of oligosaccharide/protein interactions on protein conformation and biological function of IgG antibodies suggests a potential to generate novel glycoforms of antibody molecules having unique profiles of effector functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700502     DOI: 10.1111/j.1600-065x.1998.tb01188.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  85 in total

1.  Acidic pH increases the avidity of FcgammaR for immune complexes.

Authors:  D H López; A S Trevani; G Salamone; G Andonegui; S Raiden; M Giordano; J R Geffner
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

2.  The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination.

Authors:  I B Rasmussen; E Lunde; T E Michaelsen; B Bogen; I Sandlie
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

3.  Sequence similarities of protein kinase peptide substrates and inhibitors: comparison of their primary structures with immunoglobulin repeats.

Authors:  J Kubrycht; J Borecký; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

4.  Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314.

Authors:  Ralf Kircheis; Nicole Halanek; Iris Koller; Wolfgang Jost; Manfred Schuster; Gilbert Gorr; Klaus Hajszan; Andreas Nechansky
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

Review 5.  Structure and function of natural-killer-cell receptors.

Authors:  Peter D Sun
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 6.  Engineered CD3 antibodies for immunosuppression.

Authors:  L Renders; T Valerius
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

7.  L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.

Authors:  Mioko Fujieda; Youko Aoyagi; Kousaku Matsubara; Yasuhito Takeuchi; Wakae Fujimaki; Misao Matsushita; John F Bohnsack; Shinji Takahashi
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

8.  Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.

Authors:  Falk Nimmerjahn; Robert M Anthony; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-07       Impact factor: 11.205

9.  In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner.

Authors:  Heike Albert; Mattias Collin; Diana Dudziak; Jeffrey V Ravetch; Falk Nimmerjahn
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-24       Impact factor: 11.205

10.  Aglycosylated IgG variants expressed in bacteria that selectively bind FcgammaRI potentiate tumor cell killing by monocyte-dendritic cells.

Authors:  Sang Taek Jung; Sai T Reddy; Tae Hyun Kang; M Jack Borrok; Inger Sandlie; Philip W Tucker; George Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.